[Erythema chronicum migrans Lipschütz].
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001899:Borrelia Infections / Q000150:complications / Q000276:immunology*; D002675:Child, Preschool; D004890:Erythema / Q000150:complications / Q000276:immunology*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D008193:Lyme Disease / Q000150:complications / Q000276:immunology*; D011446:Prospective Studies; D012189:Retrospective Studies; D013577:Syndrome
D000900:Anti-Bacterial Agents; D006634:Histamine H1 Antagonists; D007136:Immunoglobulins
Erythema chronikum migrans Lipschütz.